On 8 January 2018, Mr. Zhang Quancheng, President of Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. and Dr. Gao Yansong, CEO of Jiuzhitang Maker visited Stemedica Cell Technologies, Inc. Together with key department leads at Stemedica, they discussed the plan of building a manufacturing facility in Beijing and worked out a detailed plan on how to advance next steps. They also covered leverage of the Chinese government’s new policies on IND application (i.e., launching international multi-centered clinical trials) to speed up the filing process for stem cell drugs. This visit brought substantial progress to cooperative between the two sides.